Kristine D. Harper

4.2k total citations
37 papers, 3.1k citations indexed

About

Kristine D. Harper is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Kristine D. Harper has authored 37 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Orthopedics and Sports Medicine, 20 papers in Molecular Biology and 15 papers in Genetics. Recurrent topics in Kristine D. Harper's work include Bone health and osteoporosis research (25 papers), Bone Metabolism and Diseases (17 papers) and Estrogen and related hormone effects (14 papers). Kristine D. Harper is often cited by papers focused on Bone health and osteoporosis research (25 papers), Bone Metabolism and Diseases (17 papers) and Estrogen and related hormone effects (14 papers). Kristine D. Harper collaborates with scholars based in United States, Canada and France. Kristine D. Harper's co-authors include Somnath Sarkar, Dennis M. Black, Mayme Wong, Bruce Mitlak, John L. Stock, Jonathan D. Adachi, Michael W. Draper, Claude D. Arnaud, William J. Huster and Elizabeth Barrett‐Connor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Kristine D. Harper

36 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristine D. Harper United States	23	1.6k	1.1k	1.0k	913	683	37	3.1k
N. H. Bjarnason Denmark	18	1.4k 0.8×	1.3k 1.3×	1.2k 1.2×	793 0.9×	286 0.4×	31	3.1k
John L. Stock United States	23	1.8k 1.1×	646 0.6×	1.3k 1.3×	940 1.0×	643 0.9×	59	2.9k
R.A. Hannon United Kingdom	26	1.8k 1.1×	662 0.6×	1.9k 1.8×	931 1.0×	305 0.4×	55	3.1k
Zebulun D. Horowitz United States	11	1.7k 1.0×	375 0.4×	1.2k 1.2×	826 0.9×	669 1.0×	15	2.7k
Gerald Crans United States	20	1.4k 0.9×	295 0.3×	825 0.8×	634 0.7×	481 0.7×	35	2.2k
Suresh Siddhanti United States	24	3.2k 1.9×	390 0.4×	2.9k 2.9×	2.3k 2.6×	660 1.0×	54	4.7k
Pamela W. Anderson United States	26	263 0.2×	871 0.8×	350 0.3×	524 0.6×	257 0.4×	41	2.6k
D. Thiébaud Switzerland	32	1.1k 0.7×	178 0.2×	1.4k 1.4×	633 0.7×	360 0.5×	73	3.2k
Ho Yeon Chung South Korea	22	476 0.3×	177 0.2×	422 0.4×	518 0.6×	258 0.4×	73	1.8k
Piet Geusens Belgium	26	834 0.5×	84 0.1×	406 0.4×	619 0.7×	357 0.5×	66	2.7k

Countries citing papers authored by Kristine D. Harper

Since Specialization

Citations

This map shows the geographic impact of Kristine D. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine D. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine D. Harper more than expected).

Fields of papers citing papers by Kristine D. Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristine D. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine D. Harper. The network helps show where Kristine D. Harper may publish in the future.

Co-authorship network of co-authors of Kristine D. Harper

This figure shows the co-authorship network connecting the top 25 collaborators of Kristine D. Harper. A scholar is included among the top collaborators of Kristine D. Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristine D. Harper. Kristine D. Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frossard, Jean‐Louis, et al.. (2017). Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide. Diabetes Care. 40(5). 647–654. 25 indexed citations

Miličević, Zvonko, Greg Anglin, Kristine D. Harper, et al.. (2016). Low Incidence of Anti-Drug Antibodies in Type 2 Diabetes Patients Treated with Once Weekly GLP-1 Receptor Agonist Dulaglutide: Incidence of anti-drug antibodies with dulaglutide. 1 indexed citations

Miličević, Zvonko, Greg Anglin, Kristine D. Harper, et al.. (2016). Low incidence of anti‐drug antibodies in patients with type 2 diabetes treated with once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide. Diabetes Obesity and Metabolism. 18(5). 533–536. 22 indexed citations

Downs, Robert W., et al.. (2009). Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass. Osteoporosis International. 21(7). 1215–1226. 7 indexed citations

Uusi‐Rasi, Kirsti, Thomas Beck, Maithili M. Daphtary, et al.. (2006). Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. Osteoporosis International. 17(4). 575–586. 45 indexed citations

Cox, David A., Somnath Sarkar, Kristine D. Harper, & Elizabeth Barrett‐Connor. (2004). Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal women. Current Medical Research and Opinion. 20(7). 1049–1055. 6 indexed citations

Lips, Paul, et al.. (2003). Contribution of Raloxifene and Calcium and Vitamin D₃Supplementation to the Increase of the Degree of Mineralization of Bone in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 88(9). 4199–4205. 71 indexed citations

Barrett‐Connor, Elizabeth, Kristine E. Ensrud, Kristine D. Harper, et al.. (2003). Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes. Clinical Therapeutics. 25(3). 919–930. 44 indexed citations

Barrett‐Connor, Elizabeth, Deborah Grady, Andreas Sashegyi, et al.. (2002). Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women. JAMA. 287(7). 847–847. 427 indexed citations

10.

Maricic, Michael, Jonathan D. Adachi, Somnath Sarkar, et al.. (2002). Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis. Archives of Internal Medicine. 162(10). 1140–1140. 119 indexed citations

11.

Siris, Ethel S., Jonathan D. Adachi, Ying Lü, et al.. (2002). Effects of Raloxifene on Fracture Severity in Postmenopausal Women with Osteoporosis: Results from the MORE Study. Osteoporosis International. 13(11). 907–913. 67 indexed citations

12.

Pols, H.A.P., Richard Eastell, Pierre Delmas, et al.. (2001). Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with ostoporosis : 4-year results from the MORE trial. Open Repository and Bibliography (University of Liège). 2 indexed citations

13.

Eastell, Richard, Jonathan D. Adachi, Kristine D. Harper, et al.. (2000). The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis : 4-year results from the MORE trial. Open Repository and Bibliography (University of Liège). 6 indexed citations

14.

Delmas, PD, Kristine D. Harper, Wen‐Lan Wu, et al.. (2000). Effects of raloxifene on bone mineral density and biochemical markers of bone turnover in postmenopausal women with osteoporosis : 4-year results from the MORE trial. Open Repository and Bibliography (University of Liège). 1 indexed citations

15.

Johnston, C. Conrad, Nina H. Bjarnason, Fredric J. Cohen, et al.. (2000). Long-term Effects of Raloxifene on Bone Mineral Density, Bone Turnover, and Serum Lipid Levels in Early Postmenopausal Women. Archives of Internal Medicine. 160(22). 3444–3444. 151 indexed citations

16.

Harper, Kristine D. & Thomas J. Weber. (1998). SECONDARY OSTEOPOROSIS. Endocrinology and Metabolism Clinics of North America. 27(2). 325–348. 48 indexed citations

17.

Nightingale, Roger W., et al.. (1997). Strength and Stability of Posterior Lumbar Interbody Fusion. Spine. 22(11). 1181–1188. 39 indexed citations

18.

Draper, Michael W., et al.. (1996). A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women. Journal of Bone and Mineral Research. 11(6). 835–842. 274 indexed citations

19.

Harper, Kristine D., Renato V. Iozzo, & John G. Haddad. (1989). Receptors for and bioresponses to 1,25-dihydroxyvitamin D in a human colon carcinoma cell line (HT-29). Metabolism. 38(11). 1062–1069. 20 indexed citations

20.

Harper, Kristine D., James F. McLeod, M A Kowalski, & John G. Haddad. (1987). Vitamin D binding protein sequesters monomeric actin in the circulation of the rat.. Journal of Clinical Investigation. 79(5). 1365–1370. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact